PLIANT THERAPEUTICS, INC. Gain (Loss) on Extinguishment of Debt
PLIANT THERAPEUTICS, INC. (PLRX) reported Gain (Loss) on Extinguishment of Debt of -$1.83 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-03-11
- PLIANT THERAPEUTICS, INC. gain (loss) on extinguishment of debt for fiscal 2025 was -$1.83M.
- PLIANT THERAPEUTICS, INC. gain (loss) on extinguishment of debt for fiscal 2024 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|
| 2025-12-31 | -$1.83M 10-K · filed 2026-03-11 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |